All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q2 report for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) on July 18, 2025, reporting $80,000 in lobbying income.

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Pharmaceutical company.

All filings by TIBER CREEK GROUP · Everything TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$80,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169). Issues related to the One Big Beautiful Bill Act (PL 119-21).

Health Issues

Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).

Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 Preserve Access to Affordable Generics and Biosimilars Act.

Bills named in this filing 3

S. 1973
Treat and Reduce Obesity Act of 2025
S. 1041
Affordable Prescriptions for Patients Act
S. 1096
Preserve Access to Affordable Generics and Biosimilars Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.